Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Genome Medicine|October 15, 2021
Integrating thousands of PTEN variant activity and abundance measurements reveals variant subgroups and new dominant negatives in cancersKenneth A Matreyek, Jason J Stephany, Ethan Ahler, et al.
Infection and Immunity|February 23, 2013
The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiotaAnnah S Rolig, Cynthia Cech, Ethan Ahler, et al.
Protein Science : a Publication of the Protein Society|May 11, 2023
Molecular determinants of Hsp90 dependence of Src kinase revealed by deep mutational scanningVanessa Nguyen, Ethan Ahler, Katherine A Sitko, et al.
Plos One|June 7, 2013
Doxycycline alters metabolism and proliferation of human cell linesEthan Ahler, William J Sullivan, Ashley Cass, et al.
Cell Chemical Biology|September 8, 2023
Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamicsSujata Chakraborty, Ethan Ahler, Jessica J Simon, et al.
Cancer Discovery|December 12, 2012
Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatmentDaniel Braas, Ethan Ahler, Brenna Tam, et al.
Molecular Cell|April 9, 2019
A Combined Approach Reveals a Regulatory Mechanism Coupling Src's Kinase Activity, Localization, and Phosphotransferase-Independent FunctionsEthan Ahler, Ames C Register, Sujata Chakraborty, et al.
Cell Chemical Biology|August 13, 2025
Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancersWadie D Mahauad-Fernandez, Yu Chi Yang, Ian Lai, et al.
Cancer Discovery|June 22, 2026
Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant CancersKyle J Seamon, Yongxian Zhuang, Yu Chi Yang, et al.
Cancer Research|October 30, 2025
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wildtype RAS Activation in Non-Small Cell Lung CancerHitendra S Solanki, Harshit Shah, Denis Imbody, et al.
Pageof 2